You have 2 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Virus specific T-Cell

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allogeneic Stem Cell Transplant, Viral Infection Trial in Cincinnati (Viral Specific T-cells (VSTs))

Active, not recruiting
  • Allogeneic Stem Cell Transplant
  • Viral Infection
  • Viral Specific T-cells (VSTs)
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
May 5, 2021

Progressive Multifocal Leukoencephalopathy Trial (CE-VST01-JC)

Not yet recruiting
  • Progressive Multifocal Leukoencephalopathy
  • CE-VST01-JC
  • (no location specified)
Sep 14, 2022

T-bet B Cells in Persistent Virus Control After Discontinuance

Completed
  • Chronic HBV Infection
  • Drug Withdrawal
  • T-bet B cell
  • Shanghai, China
    Changhai hospital
Sep 1, 2023

High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin

Not yet recruiting
  • High Grade B-Cell Non-Hodgkin's Lymphoma
  • +3 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
  • Houston, Texas
    M D Anderson Cancer Center
Jul 13, 2022

Hepatocellular Carcinoma Trial in Singapore (mRNA HBV/TCR T-cells)

Recruiting
  • Hepatocellular Carcinoma
  • mRNA HBV/TCR T-cells
  • Singapore, Singapore
    Singapore General Hospital
Jun 27, 2022

Cytomegalovirus Infections, Hematopoietic Stem Cell Transplant, Opportunistic Infections Trial in Cleveland (CMV specific

Recruiting
  • Cytomegalovirus Infections
  • +2 more
  • CMV specific adoptive t-cells
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 26, 2022

Survival of Adult T-cell Leukemia / Lymphoma and Patients

Recruiting
  • Lymphoproliferation Induced by HTLV-1
  • +2 more
    • Paris, France
      Hôpital Necker Enfants Malades
    Sep 26, 2022

    Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

    Not yet recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • +5 more
    • Boston, Massachusetts
    • +1 more
    Jun 28, 2023

    B-Cell Non-Hodgkin Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Duarte (Anti-CD19-CAR CMV-specific T-lymphocytes, Autologous

    Not yet recruiting
    • B-Cell Non-Hodgkin Lymphoma
    • +7 more
    • Anti-CD19-CAR CMV-specific T-lymphocytes
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Jun 28, 2022

    Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

    Active, not recruiting
    • Leukemia
    • Acute Lymphoblastic Leukemia
    • gene-modified T cells targeted
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 1, 2023

    SARS-CoV-2 Infection Trial in Washington (Coronavirus-specific T cell (CST))

    Recruiting
    • SARS-CoV-2 Infection
    • Coronavirus-specific T cell (CST)
    • Washington, District of Columbia
    • +1 more
    Sep 1, 2022

    B Cell Malignancies Trial in Beijing, Shenzhen, Haikou (Universal CD19-specific CAR gene-engineered T cells)

    Recruiting
    • B Cell Malignancies
    • Universal CD19-specific CAR gene-engineered T cells
    • Beijing, Beijing, China
    • +2 more
    Aug 8, 2023

    Hepatocellular Carcinoma Trial in Guangzhou (TCR-T, No intervention and TCR-T (at crossover))

    Completed
    • Hepatocellular Carcinoma
    • TCR-T
    • No intervention and TCR-T (at crossover)
    • Guangzhou, Guangdong, China
      The First Affiliated Hospital, Sun-Yat Sen University
    Jun 27, 2022

    CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

    Active, not recruiting
    • Central Nervous System Tumor, Pediatric
    • +8 more
    • EGFR806-specific chimeric antigen receptor (CAR) T cell
    • Seattle, Washington
      Seattle Children's Hospital
    Jan 18, 2023

    Hematological Malignancies, CMV Infection Trial in Belgium (CMV-specific T cells, Standard anti-viral therapy)

    Completed
    • Hematological Malignancies
    • CMV Infection
    • CMV-specific T cells
    • Standard anti-viral therapy
    • Gent, Oost-Vlaanderen, Belgium
    • +7 more
    Dec 19, 2022

    Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

    Recruiting
    • Liver Cell Carcinoma
    • +7 more
    • CATCH T cells
    • +2 more
    • Houston, Texas
      Houston Methodist Hospital
    Dec 19, 2022

    Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

    Not yet recruiting
    • Metastatic Colorectal Adenocarcinoma
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 12, 2023

    Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

    Not yet recruiting
    • Prostate Carcinoma
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 17, 2023

    T-cell Lymphoma, Virus, Intravenous Injection Trial (Oncolytic Virus Injection(RT-01))

    Not yet recruiting
    • T-cell Lymphoma
    • +2 more
    • Oncolytic Virus Injection(RT-01)
    • (no location specified)
    May 18, 2022

    Multiple Myeloma Trial in New York (drug, biological, procedure)

    Active, not recruiting
    • Multiple Myeloma
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 3, 2023

    CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

    Recruiting
    • Central Nervous System Tumor, Pediatric
    • +8 more
    • HER2-specific chimeric antigen receptor (CAR) T cell
    • Seattle, Washington
      Seattle Children's Hospital
    Dec 14, 2022

    Solid Tumor Trial in Washington (Tumor-associated antigen-specific T cell (TAA-T))

    Recruiting
    • Solid Tumor
    • Tumor-associated antigen-specific T cell (TAA-T)
    • Washington, District of Columbia
      Children's National Hospital
    Oct 24, 2022

    MIS-C Associated With COVID-19, COVID-19 Trial in Warsaw

    Recruiting
    • MIS-C Associated With COVID-19
    • COVID-19
      • Warsaw, Masovian, Poland
        Pediatric teaching clinical hospital, Warsaw Medical University
      Sep 28, 2022

      Dengue Trial in Lausanne (LD vehicle-GNP, LD PepGNP-Dengue, HD vehicle-GNP)

      Completed
      • Dengue
      • LD vehicle-GNP
      • +3 more
      • Lausanne, Vaud, Switzerland
        Center for Primary Care and Public Health, (Unisante)
      Nov 28, 2022